A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT07158268 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07158268
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-12-20
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.